SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMhp Reg S Regulatory News (MHPC)

Share Price Information for Mhp Reg S (MHPC)

Share Price is delayed by 15 minutes
Get Live Data
8.80    0.50 (6.02%)
Bid:
8.80
Ask:
9.00
Spread: 0.20 (2.273%)
Market Cap: $941.94m
MHPC Live PriceLast checked at - London Stock Exchange

Intraday Mhp Reg S Share Chart

  • This share is an international stock.

Equity Offering by Controlling Shareholder

7 Dec 2010 16:15

RNS Number : 5398X
MHP S.A.
07 December 2010
 



THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM THE RUSSIAN FEDERATION, UKRAINE, THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

 

07 December 2010

MHP S.A.

 

Announces Equity Offering by Controlling Shareholder

 

MHP S.A. ("MHP" or the "Company", LSE ticker: "MHPC"), one of the leading agro-industrial companies in Ukraine, focusing on the production of poultry and the cultivation of grain, today announces that WTI Trading Limited (the "Selling Shareholder") is offering up to approximately 10% of the Company's ordinary shares in the form of Global Depositary Receipts ("GDRs"), including an overallotment option, with one GDR representing an interest in one share (the "Offering").

 

The Selling Shareholder, a limited liability company organised under the laws of Cyprus, is beneficially owned by Yuriy Kosiuk, the controlling beneficial shareholder and CEO of the Company.

 

The Offering includes an over-allotment option, granted by the Selling Shareholder to the joint bookrunners, to acquire additional GDRs representing up to 15% of the number of GDRs initially placed, exercisable within 30 days of announcement of the offer price.

 

The Company and the Selling Shareholder have agreed, subject to customary exceptions, to enter into a lock-up agreement for a period of 180 days following completion of the Offering.

 

The GDRs to be issued in the Offering will be listed on the London Stock Exchange pursuant to the Company's existing block listing of GDRs.

 

Morgan Stanley and UBS Investment Bank are acting as Joint Bookrunners for the Offering.

 

 

ENQUIRIES

MHP Investor Relations

Anastasiia Sobotiuk Kyiv: +38 044 207 99 58

 

Financial Dynamics

Ben Foster (London)

Marc Cohen (London)

Leonid Solovyev (Moscow)

 

 

London: +44 20 7831 3113

 

Moscow: +7 495 795 06 23

 

 

 

Important Notice

Morgan Stanley & Co International plc and UBS Limited, each of which is authorised and regulated in the UK by the Financial Services Authority, are acting exclusively for the Company and, in respect of only of the sale of GDRs, the Selling Shareholder and no one else in connection with the Offering and will not regard any other person (whether or not a recipient of this announcement) as their respective clients and will not be responsible to anyone other than the Company and the Selling Shareholder for providing the protections afforded to clients of Morgan Stanley & Co. International plc and UBS Limited nor for giving advice in relation to the Offering, the contents of this announcement or any transaction or arrangement referred to herein.

 

The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "Securities Act") or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Subject to certain exceptions, the securities referred to herein may not be offered or sold in the United Kingdom or any other European Economic Area state, Australia, Canada, Japan, Ukraine, the Russian Federation, or the United States. The offer and sale of the securities referred to herein has not been and will not be registered under the Securities Act or under the applicable securities laws of Australia, Canada, Japan, Ukraine or the Russian Federation or any other jurisdiction. There will be no public offer of the securities in the United States or elsewhere.

 

This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom (subject to applicable laws), (ii) to investment professionals falling within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") or (iii) high net worth entities falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "Relevant Persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents. Persons distributing this document must satisfy themselves that it is lawful to do so.

 

In connection with the offering, Morgan Stanley & Co. International plc (the "Stabilizing Manager") (or persons acting on behalf of the Stabilizing Manager) may (but is under no obligation to) effect transactions in the GDRs with a view to supporting the market price of the GDRs at a level higher than that which might otherwise have prevailed in the open market. However, there is no assurance that the Stabilizing Manager (or persons acting on behalf of the Stabilizing Manager) will undertake stabilization action. Any stabilization action may begin on or after the date on which adequate public disclosure of the final price of the global depositary receipts is made and, if begun, may be ended at any time, but it must end no later than 30 days after the date of such adequate public disclosure of the final price of the GDRs. Any stabilization action must be conducted by the Stabilizing Manager (or person(s) acting on behalf of the Stabilizing Manager) in accordance with all applicable laws and rules. Save as required by law or regulation, neither the Stabilizing Manager nor any of its agents intends to disclose the extent of any stabilization transactions conducted in relation to the Offering.

 

This document is an advertisement and is not a prospectus for the purposes of EU Directive 2003/71/EC (the "Prospectus Directive") and Part VI of the Financial Services and Markets Act 2000 (the "FSMA"). In any EEA Member State that has implemented the Prospectus Directive this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.

 

In connection with the Offering, Morgan Stanley & Co. International plc or UBS Limited, or any of their respective affiliates, acting as investors for their own accounts, may subscribe for or purchase GDRs and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such GDRs and other securities of the Company or related investments in connection with the Offering or otherwise. Accordingly, references to the GDRs being issued, offered, subscribed, acquired, placed or otherwise dealt in should be read as including any issue or offer to, or subscription, acquisition, placing or dealing by Morgan Stanley & Co. International plc or UBS Limited or any of their respective affiliates acting as investors for their own accounts. Morgan Stanley & Co. International plc and UBS Limited do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

 

The offer and the distribution of this press release and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

 

This announcement and information contained therein are for information purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy or completeness. Information in this announcement cannot be relied upon as a guide to future performance. The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISTRBFTMBBMBTM
Date   Source Headline
1st Jun 20267:00 amRNSMHP SE to acquire up to 100% of Th. Nitsiakos AVEE
8th May 20267:34 amRNSMHP SE Notice of Annual General Meeting
5th May 20267:04 amRNSFinancial Results for the Q4 and 12M
17th Feb 20261:10 pmRNSMHP 2026 NOTES REDEMPTION PRICE ANNOUNCEMENT
13th Feb 20269:34 amRNSMHP LUX S.A. ANNOUNCES RESULTS OF TENDER OFFER
10th Feb 202610:32 amRNSMHP SE TAP OFFERING CLOSING ANNOUNCEMENT
4th Feb 20267:00 amRNSMHP Tap Pricing Announcement
3rd Feb 20269:11 amRNSMHP Tap Launch Announcement
28th Jan 202611:21 amRNSMHP NEW EUROBOND CLOSING ANNOUNCEMENT
22nd Jan 20267:00 amRNSMHP SE - Eurobond 2026 - Pricing Announcement
15th Jan 20261:28 pmRNSMHP 2026 NOTES CONDITIONAL REDEMPTION ANNOUNCEMENT
15th Jan 20261:12 pmRNSMHP SE NEW EUROBOND MANDATE AND TENDER OFFER
15th Jan 202612:57 pmRNSMHP LUX S.A. - INVITATION TO PURCHASE NOTES
15th Dec 20257:00 amRNSMHP SE Financial Results for the Q3 and 9 M 2025
9th Dec 20252:07 pmRNSMHP SE Results of EGM 09 December 2025
14th Nov 20252:14 pmRNSNotification about GDRs Purchase by PDMR of MHP
7th Nov 20258:25 amRNSConvening Notice of Extraordinary General Meeting
12th Sep 20257:00 amRNSFinancial Results for the Q2 and 6M 2025
4th Aug 20257:00 amRNSMHP Closes Acquisition of 92% Stake in Grupo UVESA
16th Jun 20251:39 pmRNSMHP SE Results of AGM 2025
21st May 20257:00 amRNSFinancial Results for the First Quarter 2025
14th May 20258:58 amRNSNotice of Annual General Meeting 2025
28th Apr 20257:09 amRNSFinancial Results Q4 and 12M 2024
28th Apr 20257:00 amRNSMHP acquires 91.77% of UVESA
21st Mar 20257:00 amRNSMHP signs Share Purchase Agreement with UVESA
11th Dec 20247:00 amRNSMHP offers to acquire UVESA Group
10th Dec 20241:08 pmRNSPress release on EGM result
22nd Nov 20247:10 amRNSFinancial Results for Q3 and 9M 2024
5th Nov 202411:33 amRNSNotice of Extraordinary General Meeting
17th Sep 202412:31 pmRNSDisclosure Notification
6th Sep 20249:29 amRNSFinancial Results for Q2 and 6M 2024 replace
19th Jun 202410:34 amRNSResults of AGM
4th Jun 20247:37 amRNSFinancial Results for the First Quarter 2024
17th May 20248:47 amRNSConvening Notice - AGM 2024
17th May 20247:22 amRNSBoard Changes
10th May 20247:58 amRNS2024 Eurobond Repayment
2nd May 20247:30 amRNS2023 Integrated Annual Report and Press Statement
11th Mar 20241:02 pmRNSEGM Results
7th Feb 202412:41 pmRNSEGM- Convening Notice
23rd Jan 20249:54 amRNSAppointment of a new ARC Chair
16th Nov 20237:13 amRNSQ3 and 9M 2023 Financial Results
25th Sep 20239:02 amRNSFinancial Statement Q2 2023
21st Sep 20237:06 amRNSDate Notification Q2 2023 Results
8th Sep 20237:00 amRNSMHP SE Invests in Saudi Arabia
19th Jun 20238:41 amRNSAGM results
18th May 20237:00 amRNSQ1 2023 Financial and Operational Results
17th May 202311:00 amRNSAGM Convening Notice
11th Apr 20239:42 amRNSMHP SE Standalone FS 2022
11th Apr 20239:27 amRNSMHP SE Standalone FS 2022
11th Apr 20238:54 amRNSMHP SE Standalone 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.